AMPLIFY-201
Phase 1 Completed
25 enrolled 15 charts
Testing the Addition of a Radiation Sensitizing Drug, IPdR, to the Usual Chemotherapy Treatment (Capecitabine) During Radiation Therapy for Rectal Cancer
Phase 1 Terminated
1 enrolled 7 charts
CEDAR
Phase 1 Completed
12 enrolled 13 charts
A Multi-Center, Open-Label Study of Fruquintinib in Solid Tumors and Colorectal, and Breast Cancers
Phase 1 Completed
129 enrolled 32 charts
Talimogene Laherparepvec, Chemotherapy, and Radiation Therapy Before Surgery in Treating Patients With Locally Advanced or Metastatic Rectal Cancer
Phase 1 Terminated
3 enrolled 9 charts
Ipilimumab and Local Radiation for Selected Solid Tumors
Phase 1 Terminated
3 enrolled 5 charts
Monoclonal Antibody Therapy in Treating Patients With Advanced Colorectal Cancer
Phase 1 Terminated
7 enrolled 8 charts
Exploratory Study of TG02-treatment as Monotherapy or in Combination With Pembrolizumab to Assess Safety and Immune Activation in Patients With Locally Advanced Primary and Recurrent Oncogenic RAS Exon 2 Mutant Colorectal Cancer
Phase 1 Terminated
6 enrolled 11 charts
Chemoembolization Using Irinotecan in Treating Patients With Liver Metastases From Metastatic Colon or Rectal Cancer
Phase 1 Terminated
4 enrolled 6 charts
A Phase I Study of AZD6244 in Combination With Capecitabine and Radiotherapy in Locally Advanced Adenocarcinoma of the Rectum
Phase 1 Terminated
1 enrolled 7 charts
BrUOG 302:BYL719, Capecitabine and Radiation for Rectal Cancer: A Brown University Oncology Research Group Study
Phase 1 Terminated
7 enrolled 7 charts
Preoperative CRT With Temozolomide Plus Capecitabine in Rectal Cancer
Phase 1 Completed
22 enrolled 5 charts
Dose Escalation Trial of Nitroglycerin, 5-flourouracil and Rad Therapy for Rectal Cancer
Phase 1 Completed
13 enrolled 8 charts
PILLAR II
Phase 1 Completed
147 enrolled 14 charts
Safety Study of Capecitabine With Radiation in Elderly Rectal Cancer
Phase 1 Completed
24 enrolled 10 charts
Study of Postoperative Concurrent Chemo-radiation With Capecitabine in Elderly Rectal Cancer Patients
Phase 1 Completed
18 enrolled 10 charts
A Study of Irinotecan, Levofolinate, and 5-Fluorouracil (FOLFIRI) Plus Ramucirumab (IMC-1121B)
Phase 1 Completed
6 enrolled 12 charts